For millions of women, the years surrounding menopause bring a cascade of symptoms — hot flashes, brain fog, disrupted sleep, weight gain, mood changes, and a dramatic shift in sexual health. Hormone replacement therapy (HRT) has been used for decades to address these changes, yet it remains one of the most misunderstood and fear-laden topics in women's medicine. This guide cuts through the noise with up-to-date, evidence-based information so you can have an informed conversation with your provider.
What Happens to Hormones During Menopause?
Menopause — defined as 12 consecutive months without a menstrual period — marks the end of ovarian hormone production. The transition (perimenopause) typically begins in the mid-to-late 40s and can last 4–10 years. During this time, three key hormones decline significantly:
- Estrogen (primarily estradiol): The primary female sex hormone responsible for bone density, cardiovascular health, vaginal lubrication, skin elasticity, and mood regulation.
- Progesterone: Produced in the second half of the menstrual cycle; it counterbalances estrogen and supports sleep, mood, and uterine health.
- Testosterone: Often overlooked in women, testosterone supports libido, energy, muscle mass, cognitive sharpness, and overall sense of well-being. Women produce it in small but meaningful quantities, and levels drop by roughly 50% between ages 20–45.
The resulting hormonal imbalance drives the wide range of symptoms women experience — and HRT works by partially restoring these levels to a physiologically younger range.
Types of HRT: What Are Your Options?
Estrogen-Only HRT
Prescribed to women who have had a hysterectomy. Estrogen alone is highly effective for vasomotor symptoms (hot flashes, night sweats) and genitourinary symptoms. It comes in multiple delivery formats including patches, gels, sprays, and oral tablets. Transdermal (skin-applied) estrogen bypasses the liver and is generally associated with a better safety profile regarding blood clots compared to oral formulations.
Combined Estrogen + Progesterone HRT
For women with an intact uterus, progesterone (or a synthetic progestogen) must be added to protect the uterine lining from estrogen-driven overgrowth. Progesterone can be taken as oral micronized progesterone (often called "body-identical" or "bioidentical"), via the Mirena IUD (local delivery), or as a patch combined with estrogen.
Testosterone Therapy for Women
Low-dose testosterone is increasingly recognized as a valuable component of women's HRT, particularly for hypoactive sexual desire disorder (HSDD), low energy, and cognitive concerns. While no testosterone product is currently FDA-approved specifically for women, off-label use of low-dose gels, creams, or pellets is widely practiced by hormone-specialized clinicians. Women require roughly 10–20 times less testosterone than men, so dosing must be carefully calibrated.
Local (Vaginal) Estrogen
Vaginal estrogen creams, rings, and tablets deliver estrogen directly to the vaginal and urethral tissues with minimal systemic absorption. This is highly effective for genitourinary syndrome of menopause (GSM) — dryness, painful intercourse, recurrent UTIs — and is generally considered safe even for women who cannot use systemic HRT.
The WHI Study — What It Said vs. What It Meant
In 2002, the Women's Health Initiative (WHI) trial was halted early when researchers reported increased rates of breast cancer, heart disease, and stroke in women taking combined oral estrogen + progestin. The medical community largely abandoned HRT, and millions of women were left without treatment for debilitating symptoms.
Twenty-plus years of subsequent research has significantly revised these conclusions:
- The WHI used oral conjugated equine estrogen + medroxyprogesterone acetate (MPA) — synthetic hormones, not body-identical ones.
- The average age of participants was 63 — well past the critical "window of opportunity" for cardioprotective benefits.
- Women who begin HRT within 10 years of menopause onset (or before age 60) show a different risk-benefit profile than older, symptomatic women.
- The absolute risk increases were small; many were later shown to be non-significant.
Current guidance from the Menopause Society (formerly NAMS), the British Menopause Society, and the Endocrine Society supports HRT as a first-line treatment for menopausal symptoms in appropriate candidates, particularly those under 60 or within 10 years of menopause.
Risks vs. Benefits: An Honest Assessment
| Outcome | HRT Effect | Notes |
|---|---|---|
| Vasomotor symptoms (hot flashes) | ✅ Significantly reduced | Most effective available treatment |
| Bone density / osteoporosis | ✅ Protective | Reduces fracture risk substantially |
| Cardiovascular disease | ✅ Potentially protective (if started early) | "Timing hypothesis" — benefit in <60 / <10 yrs post-menopause |
| Type 2 diabetes risk | ✅ Reduced | Improves insulin sensitivity |
| Genitourinary health | ✅ Markedly improved | Particularly with vaginal estrogen |
| Breast cancer (combined HRT) | ⚠️ Small increase with long-term use | Risk similar to or less than daily alcohol consumption |
| Blood clots (VTE) | ⚠️ Small increase (oral estrogen) | Transdermal estrogen does not increase VTE risk |
| Stroke | ⚠️ Slight increase (oral only) | Not seen with transdermal formulations |
| Cognitive function / dementia | 🔬 Under study | Early data suggests possible neuroprotection when started timely |
Who Is a Good Candidate for HRT?
Most healthy women under 60 with menopausal symptoms are considered appropriate candidates. The decision is individualized — your provider will consider:
- Severity of symptoms and their impact on quality of life
- Age at menopause and years since menopause
- Personal and family history of breast cancer, blood clots, cardiovascular disease, or stroke
- Bone density (DEXA scan results)
- Uterine status (hysterectomy vs. intact)
- Lifestyle factors and comorbidities
Women who may need extra caution or alternatives include those with a personal history of hormone receptor-positive breast cancer, unexplained vaginal bleeding, active liver disease, or recent cardiovascular event. Always consult your provider for a complete evaluation before starting or stopping HRT.
How to Start HRT — The Telehealth Approach
Accessing HRT has traditionally required navigating primary care physicians, OB/GYNs, and often long wait times. Telehealth has changed that equation. Through platforms like Truventa Medical, you can:
- Complete a comprehensive symptom intake and medical history online
- Order baseline lab work (estradiol, FSH, progesterone, testosterone, SHBG, thyroid panel, CBC, metabolic panel)
- Meet with a licensed clinician via video who specializes in women's hormonal health
- Receive a personalized prescription, often including compounded or FDA-approved formulations
- Access ongoing monitoring and dose adjustments without leaving home
Monitoring and Optimization
HRT is not a "set it and forget it" therapy. Effective management includes:
- Follow-up labs at 6–12 weeks after initiation to assess hormone levels and liver/lipid markers
- Annual review of risks, benefits, and ongoing need
- Mammography per age-appropriate guidelines
- Bone density monitoring every 2 years if on HRT for osteoprotective purposes
- Blood pressure checks, particularly for women on oral estrogen
Related Topics Worth Exploring
Women considering HRT often benefit from understanding related topics like bioidentical hormone therapy, how sleep affects hormones, and the role of cortisol in weight gain. A comprehensive hormonal health approach addresses the full picture.
Frequently Asked Questions
How long does it take for HRT to work?
Many women notice improvements in hot flashes and sleep within 2–4 weeks. Vaginal and genitourinary improvements may take 8–12 weeks. Mood and energy changes can take 2–3 months, and bone density effects are measured over years. Individual response varies — work with your provider to track progress.
Is there a minimum or maximum age to start HRT?
There's no strict age cutoff, but starting HRT before age 60 or within 10 years of menopause tends to offer the most favorable benefit-risk ratio. Women over 60 can still benefit, particularly for genitourinary symptoms, but the discussion requires careful individualization with a provider familiar with the nuances.
Can HRT cause weight gain?
A common concern — but the evidence suggests HRT does not cause weight gain and may actually help prevent the redistribution of fat to the abdomen that occurs with estrogen loss. Some women experience initial fluid retention, which typically resolves. Overall, hormone optimization often makes maintaining a healthy weight easier, not harder.
What's the difference between "bioidentical" and "synthetic" hormones?
Bioidentical hormones are chemically identical to those the human body produces. Synthetic hormones (like MPA used in the WHI study) differ in molecular structure. Many FDA-approved HRT products (e.g., estradiol, micronized progesterone) are technically bioidentical. See our full guide on bioidentical hormone therapy for a deeper dive.
Do I need HRT if I'm only in perimenopause?
Perimenopausal symptoms can be just as disruptive as postmenopausal ones. HRT (often at lower doses) can be appropriate during perimenopause to manage symptoms and support health. However, contraception must still be considered since ovulation can still occur. Discuss your full reproductive status with your provider.